News

radiology reporting EHR health record CDS AUC

PocketHealth's latest agentic AI offering improves patient compliance, reduces administrative costs

Conductor is a platform of AI-enabled agents that can read clinical documents and orders, call patients and orchestrate appointments.

Some reviewers opposed FDA's approval of new drug for life-threatening disease

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision.

Eating unsalted peanuts improves the brain's vascular health

MRIs show how peanut consumption improves the brain's vascular function

Consistently incorporating unsalted peanuts into a person’s diet enhances cerebral blood flow to multiple brain regions.

Healthcare AI today: Billions for AI-based biotech, fast ROI or else, AI for imprisoned patients, more

The Zuckerbergs have many billions to give away. They want to shower a lot of it on researchers using AI to cure diseases.

Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.

CCTA will play an essential role in the cath labs of the future

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview.

Is long-term melatonin use safe? New study highlights heart risks

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep.

GLP-1 drugs and healthy lifestyle choices work in tandem to protect the heart

The rise of these medications continues to be one of the biggest stories in healthcare.

GLP-1 weight loss drugs will now be covered by Medicare and Medicaid—and available at a discount through TrumpRx

Novo Nordisk and Eli Lilly have agreed to sell their popular Wegovy and Zepbound injectables through TrumpRx.gov for a discounted rate, as the White House promises that Medicaid and Medicare plans will begin covering the costs.

COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination

Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

How to minimize bleeding risks after TAVR

Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum.

Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished

Clinicians who come to rely on AI for decision support risk the dulling of their skills. The concern is not new. But now comes a pointed call to researchers: Inquire about the particulars of the peril.

Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly

Pfizer was all set to acquire New York City-based Metsera for $4.9 billion, but Novo Nordisk stepped in with an unexpected counteroffer of $6.5 billion. Both companies hope to add Metsera's drugs to their GLP-1 portfolios.

Around the web

Radiology Business